ARTICLE | Clinical News

Dysport botulinum regulatory update

October 6, 2008 7:00 AM UTC

Ipsen said FDA pushed back the PDUFA date for a BLA for Dysport botulinum toxin type A to treat cervical dystonia by 3 months to Dec. 28 from Sept. 29 after FDA requested the company submit a Risk Com...